ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Sysmex Corp.

Business Summary

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2021 JPYUSD
Revenue305,073M2,876.48M
Gross Profit154,303M1,454.90M
Operating income50,947M480.37M
Income before tax51,116M481.96M
Net income33,142M312.49M
EBITDA76,522M721.51M
Diluted EPS158.381.49
Dividends Per Share720.67
Total Assets427,475M3,868.55M
Total liabilities118,801M1,075.12M
Total equity307,898M2,786.40M
Operating cash flow58,813M554.53M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 249,899M 281,935M 293,506M 301,980M 305,073M
Gross Profit 141,777M 158,949M 161,607M 159,807M 154,303M
Operating income 50,822M 59,947M 60,799M 54,501M 50,947M
Income before tax 48,946M 58,117M 57,955M 49,433M 51,116M
Net income 40,635M 39,221M 41,224M 34,882M 33,142M
EBITDA 63,203M 74,590M 76,641M 78,456M 76,522M
Diluted EPS 194.74 187.84 197.28 166.92 158.38
Dividends Per Share 58 66 70 72 72
Total Assets 279,817M 321,979M 346,775M 389,291M 427,475M
Total liabilities 71,248M 80,531M 81,588M 110,941M 118,801M
Total equity 209,407M 240,750M 264,449M 277,684M 307,898M
Operating cash flow 32,832M 52,240M 44,743M 53,182M 58,813M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 2,307.73M 2,543.79M 2,646.70M 2,777.44M 2,876.48M
Gross Profit 1,309.26M 1,434.13M 1,457.30M 1,469.81M 1,454.90M
Operating income 469.32M 540.87M 548.25M 501.27M 480.37M
Income before tax 452.00M 524.36M 522.61M 454.65M 481.96M
Net income 375.25M 353.87M 371.74M 320.82M 312.49M
EBITDA 583.65M 672.99M 691.11M 721.59M 721.51M
Diluted EPS 1.79 1.69 1.77 1.53 1.49
Dividends Per Share 0.53 0.59 0.63 0.66 0.67
Total Assets 2,511.14M 3,027.54M 3,132.99M 3,606.04M 3,868.55M
Total liabilities 639.39M 757.22M 737.11M 1,027.65M 1,075.12M
Total equity 1,879.26M 2,263.75M 2,389.20M 2,572.21M 2,786.40M
Operating cash flow 303.19M 471.34M 403.47M 489.13M 554.53M

Valuation Measures

Mar 2021
PER75.16
ROA8.11%
ROE11.31%
Operating margin16.69%
Profit margin10.86%

Key executives

  • Chairman, Chief Executive Officer & President: Hisashi Ietsugu
  • Director, CTO & COO-LS Business Unit: Kaoru Asano
  • CFO, Director & Senior Managing Executive Officer: Yukio Nakajima
  • Manager-Informatics: Yasuhiro Takachi
  • Executive Officer: Keiji Fujimoto

Shareholders

  • Baillie Gifford & Co. (5.9%)
  • Kobe Yamabuki Foundation (5.7%)
  • Nakatani Foundation (5.6%)
  • Nakatani Kosan YK (4.9%)
  • IETSUGU KAZUKO (2.9%)
  • WADA TAEKO (2.9%)
  • BlackRock Fund Advisors (2.7%)
  • Nomura Asset Management Co., Ltd. (2.6%)
  • IETSUGU FAMILY (2.2%)
  • The Vanguard Group, Inc. (2.2%)

Contact Details

  • Website:http://www.sysmex.co.jp
  • Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
  • Phone: +81.78.265.0500

Related Companies

  • Oxford Gene Technology (Operations) Ltd.
  • Sysmex Medical Electronics (Shanghai) Co., Ltd.
  • Sysmex Wuxi Co. Ltd.
  • Sysmex Inostics, Inc.
  • Sysmex Turkey Diagnostik Sistemleri Ltd. STI
  • Sysmex (Malaysia) Sdn.Bhd.
  • Sysmex Vietnam Co. Ltd.
  • Sysmex Taiwan Co. Ltd.
  • Sysmex Suisse AG
  • Sysmex Slovakia sro
  • Sysmex Shanghai Ltd.
  • Sysmex RUS LLC
  • Sysmex Polska Sp zoo
  • Sysmex Philippines, Inc.
  • Sysmex Hungaria Kft.
  • Sysmex Hong Kong Ltd.
  • Sysmex Espana SL
  • Sysmex do Brasil Industria e Comercio Ltda.
  • Sysmex CZ sro
  • Sysmex Canada, Inc.
  • Sysmex Austria GmbH
  • Sysmex Middle East FZ LLC
  • Sysmex South Africa (Pty) Ltd.
  • Sysmex Inostics GmbH
  • Sysmex Korea Co., Ltd.
  • Katakura Industries Co. Ltd. /Biological Research Center/
  • Sysmex RA Co. Ltd.
  • Sysmex Europe GmbH
  • Sysmex Deutschland GmbH
  • Sysmex TMC Co., Ltd.

Competitors

  • bioMerieux SA
  • Haemonetics Corporation
  • Bio-Techne Corporation
  • Guardant Health, Inc.
  • Autobio Diagnostics Co., Ltd. Class A
  • Epigenomics AG
  • Biocept, Inc.
Last Updated on 11 Jun, 2021

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more